Carnegie Mellon University
Pittsburgh, Pennsylvania, 15213, United States
NCT Number: NCT05925556
We plan to develop a communal coping intervention aimed at instilling a shared appraisal of diabetes and increasing patient-partner collaboration. To that end, we will pilot the first randomized clinical trial of a brief communal coping intervention among couples in which one person has T1D
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15213, United States
We will recruit 66 couples in which one person has type 1 diabetes. Power is based on effect sizes from previous couple intervention studies and meta-analyses on primary outcomes. Couples will be randomly assigned to either a communal coping intervention or an attention (diabetes education) control group. All couples will come to the laboratory or meet via zoom, complete a baseline questionnaire assessment (primary and secondary outcomes, mediators) and have a videotaped conversation about how they cope with diabetes. The intervention group will receive the communal coping intervention. Couples in the intervention group will identify 5 collaborative implementation intentions, whereas controls will identify 5 individual implementation intentions. After the in-person session, couples will individually complete a daily diary at the end of the day for 14 consecutive days which focuses on daily communication, mood, and patient self-care. During the first 7 days, the intervention group will receive two text messages per day (morning focus on shared appraisal, evening focus on one of collaborative implementation intentions identified during in-person session). An in-person follow-up interview will take place 6 weeks after the initial session, during which primary outcomes, secondary outcomes, and mediators will be assessed and the videotaped conversation repeated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The components of the intervention were described in the experimental arm.
Time frame: baseline, abbreviated for ecological momentary assessment, 6-week followup
diabetes distress
Time frame: baseline, abbreviated for ecological momentary assessment, 6-week followup
self-management
Time frame: baseline, 6 week followup
test kit
Time frame: baseline (from past 2 weeks), end of 2-week ecological momentary assessment (from past 2 weeks), 6-week followup (past 2 weeks)
data downloaded from continuous glucose monitors
Time frame: baseline, abbreviated for ecological momentary assessment, 6-week followup
depressive symptoms
Time frame: baseline, abbreviated for ecological momentary assessment, 6-week followup
life satisfaction
Time frame: baseline, abbreviated for ecological momentary assessment, 6-week followup
relationship quality
Time frame: baseline, abbreviated for ecological momentary assessment, 6-week followup
self-reports of communal coping, raters coding of communal coping from videotapes, we-talk from brief interview
Time frame: baseline, abbreviated for for ecological momentary assessment, 6-week followup
emotional, instrumental, informational support, criticism, overprotective behavior
Time frame: baseline, abbreviated for for ecological momentary assessment, 6-week followup
self-report of diabetes communication, videotaped observations
Time frame: baseline, abbreviated for for ecological momentary assessment, 6-week followup
self-efficacy with diabetes management
Carnegie Mellon University
Other
Communal Coping Intervention for Adults With Type 1 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06236256
Autoimmune Diseases, Diabetes Mellitus
Ramat Gan, Israel
View Trial DetailsNCT07711275
Autoimmune Diseases, Diabetes Mellitus
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsNCT07090824
Autoimmune Diseases, Diabetes Mellitus
Palo Alto, California, United States
View Trial Details